Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of HSK47388 Tablets in moderate-to-severe plaque psoriasis
CTR20253452Phase 2Active
- Sponsor
- Haisco Pharmaceutical Group Co., Ltd.
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of HSK47388 in plaque psoriasis, sponsored by Haisco Pharmaceutical Group Co., Ltd.. Started Sep 2025; status: active.
02
Drugs
HSK47388
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on CTR20253452.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20253452.